Pivotal Therapeutics Inc
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue 94 -
Cost of Revenue 41 -
Gross Profit 53 -
Operating Expenses
Research and Development 472 588
Sales, General and Admin. 3,163 3,113
Non-Recurring Items - -
Other 49 29
Operating Income (3,631) (3,730)
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax (3,631) (3,730)
Interest Expense - -
Earnings Before Tax (3,631) (3,730)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (3,631) (3,730)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (3,631) (3,730)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (3,631) (3,730)